Contact:

The Quigley Corporation Urges Investigation of Unattributed "Research"

DOYLESTOWN, PA, July 22, 2002 - The Quigley Corporation (Nasdaq: QGLY) today issued the following statement related to an unattributed website posting about the Company:

"It is clear this so-called report was created as part of a deliberate attack on the Company and the interests of its shareholders and may well be an illegal attempt at stock manipulation by its author or authors.

The information presented is misleading and comes from a website that does not contain the names of its creators, no address, no phone number and absolutely no credentials.

No one at The Quigley Corporation was contacted for this report. We have referred this matter to the Company's legal counsel and urge the proper legal and regulatory bodies to thoroughly pursue the perpetrators responsible for this website content.

The Quigley Corporation continues to execute its strategy of new product introductions and focused marketing strategy for our flagship Cold-Eeze® brand as well as the promising launch of Quigley Pharma as core elements of its strategy to produce sustainable profitability and enhanced shareholder value."

About The Quigley Corporation
Founded in 1989, The Quigley Corporation (Nasdaq: QGLY) is a leading developer and marketer of diversified health products including the Cold-Eeze® family of patented zinc gluconate glycine (ZIGG™) lozenges, gums and sugar free tablets. Cold-Eeze is the only (ZIGG™) lozenge proven in two double-blind studies to reduce the duration of the common cold from 7.6 to 4.4 days or by 42%. In addition to Over-The-Counter (OTC) products, the Company has formed Quigley Pharma Inc. (http://www.QuigleyPharma.com), a wholly owned ethical pharmaceutical subsidiary, to introduce a line of patented prescription drugs. The Quigley Corporation's customers include leading national wholesalers and distributors, as well as independent and chain food, drug and mass merchandise stores and pharmacies.

Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and involve known and unknown risk, uncertainties and other factors that may cause the Company's actual results, performance or achievements to be materially different from the results, performance or achievements expressed or implied by the forward-looking statement. Factors that impact such forward-looking statements include, among others, changes in worldwide general economic conditions, changes in interest rates, government regulations, and worldwide competition.